RxDB
ICD-10-PCS Codes Browse (Tables)

ICD-10 PCS – Browse (Tables)

Code Title
– Top Categories
3 Administration
3E Physiological Systems and Anatomical Regions
3E0 Introduction Administration, Physiological Systems and Anatomical Regions, Introduction
3E04 Central Vein
3E040 Open
3E0400 Antineoplastic
3E04002 High-dose Interleukin-2 Introduction of High-dose Interleukin-2 into Central Vein, Open Approach
3E04003 Low-dose Interleukin-2 Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach
3E04005 Other Antineoplastic Introduction of Other Antineoplastic into Central Vein, Open Approach
3E0400M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach
3E0400P Clofarabine Introduction of Clofarabine into Central Vein, Open Approach
3E0401 Thrombolytic
3E04016 Recombinant Human-activated Protein C Introduction of Recombinant Human-activated Protein C into Central Vein, Open
3E04017 Other Thrombolytic Introduction of Other Thrombolytic into Central Vein, Open Approach
3E0402 Anti-infective
3E04028 Oxazolidinones Introduction of Oxazolidinones into Central Vein, Open Approach
3E04029 Other Anti-infective Introduction of Other Anti-infective into Central Vein, Open Approach
3E0403 Anti-inflammatory
3E0403Z No Qualifier Introduction of Anti-inflammatory into Central Vein, Open Approach
3E0404 Serum, Toxoid and Vaccine
3E0404Z No Qualifier Introduction of Serum, Toxoid and Vaccine into Central Vein, Open Approach
3E0406 Nutritional Substance
3E0406Z No Qualifier Introduction of Nutritional Substance into Central Vein, Open Approach
3E0407 Electrolytic and Water Balance Substance
3E0407Z No Qualifier Introduction of Electrolytic and Water Balance Substance into Central Vein, Open Approach
3E040F Intracirculatory Anesthetic
3E040FZ No Qualifier Introduction of Intracirculatory Anesthetic into Central Vein, Open Approach
3E040G Other Therapeutic Substance
3E040GC Other Substance Introduction of Other Therapeutic Substance into Central Vein, Open Approach
3E040GN Blood Brain Barrier Disruption Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Open Approach
3E040H Radioactive Substance
3E040HZ No Qualifier Introduction of Radioactive Substance into Central Vein, Open Approach
3E040K Other Diagnostic Substance
3E040KZ No Qualifier Introduction of Other Diagnostic Substance into Central Vein, Open Approach
3E040N Analgesics, Hypnotics, Sedatives
3E040NZ No Qualifier Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Open Approach
3E040P Platelet Inhibitor
3E040PZ No Qualifier Introduction of Platelet Inhibitor into Central Vein, Open Approach
3E040R Antiarrhythmic
3E040RZ No Qualifier Introduction of Antiarrhythmic into Central Vein, Open Approach
3E040T Destructive Agent
3E040TZ No Qualifier Introduction of Destructive Agent into Central Vein, Open Approach
3E040V Hormone
3E040VG Insulin Introduction of Insulin into Central Vein, Open Approach
3E040VH Human B-type Natriuretic Peptide Introduction of Human B-type Natriuretic Peptide into Central Vein, Open Approach
3E040VJ Other Hormone Introduction of Other Hormone into Central Vein, Open Approach
3E040W Immunotherapeutic
3E040WK Immunostimulator Introduction of Immunostimulator into Central Vein, Open
3E040WL Immunosuppressive Introduction of Immunosuppressive into Central Vein, Open
3E040X Vasopressor
3E040XZ No Qualifier Introduction of Vasopressor into Central Vein, Open Approach
3E043 Percutaneous
3E0430 Antineoplastic
3E04302 High-dose Interleukin-2 Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach
3E04303 Low-dose Interleukin-2 Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach
3E04305 Other Antineoplastic Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach
3E0430M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach
3E0430P Clofarabine Introduction of Clofarabine into Central Vein, Percutaneous Approach
3E0431 Thrombolytic
3E04316 Recombinant Human-activated Protein C Introduction of Recombinant Human-activated Protein C into Central Vein, Percutaneous
3E04317 Other Thrombolytic Introduction of Other Thrombolytic into Central Vein, Percutaneous Approach
3E0432 Anti-infective
3E04328 Oxazolidinones Introduction of Oxazolidinones into Central Vein, Percutaneous Approach
3E04329 Other Anti-infective Introduction of Other Anti-infective into Central Vein, Percutaneous Approach
3E0433 Anti-inflammatory
3E0433Z No Qualifier Introduction of Anti-inflammatory into Central Vein, Percutaneous Approach
3E0434 Serum, Toxoid and Vaccine
3E0434Z No Qualifier Introduction of Serum, Toxoid and Vaccine into Central Vein, Percutaneous Approach
3E0436 Nutritional Substance
3E0436Z No Qualifier Introduction of Nutritional Substance into Central Vein, Percutaneous Approach
3E0437 Electrolytic and Water Balance Substance
3E0437Z No Qualifier Introduction of Electrolytic and Water Balance Substance into Central Vein, Percutaneous Approach
3E043F Intracirculatory Anesthetic
3E043FZ No Qualifier Introduction of Intracirculatory Anesthetic into Central Vein, Percutaneous Approach
3E043G Other Therapeutic Substance
3E043GC Other Substance Introduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach
3E043GN Blood Brain Barrier Disruption Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Percutaneous Approach
3E043GQ Glucarpidase Introduction of Glucarpidase into Central Vein, Percutaneous Approach
3E043H Radioactive Substance
3E043HZ No Qualifier Introduction of Radioactive Substance into Central Vein, Percutaneous Approach
3E043K Other Diagnostic Substance
3E043KZ No Qualifier Introduction of Other Diagnostic Substance into Central Vein, Percutaneous Approach
3E043N Analgesics, Hypnotics, Sedatives
3E043NZ No Qualifier Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Percutaneous Approach
3E043P Platelet Inhibitor
3E043PZ No Qualifier Introduction of Platelet Inhibitor into Central Vein, Percutaneous Approach
3E043R Antiarrhythmic
3E043RZ No Qualifier Introduction of Antiarrhythmic into Central Vein, Percutaneous Approach
3E043T Destructive Agent
3E043TZ No Qualifier Introduction of Destructive Agent into Central Vein, Percutaneous Approach
3E043V Hormone
3E043VG Insulin Introduction of Insulin into Central Vein, Percutaneous Approach
3E043VH Human B-type Natriuretic Peptide Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach
3E043VJ Other Hormone Introduction of Other Hormone into Central Vein, Percutaneous Approach
3E043W Immunotherapeutic
3E043WK Immunostimulator Introduction of Immunostimulator into Central Vein, Percutaneous
3E043WL Immunosuppressive Introduction of Immunosuppressive into Central Vein, Percutaneous
3E043X Vasopressor
3E043XZ No Qualifier Introduction of Vasopressor into Central Vein, Percutaneous Approach